SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-016630
Filing Date
2022-04-28
Accepted
2022-04-28 17:02:50
Documents
5
Period of Report
2022-06-07

Document Format Files

Seq Description Document Type Size
1 DEF14A ny20003206x1_def14a.htm DEF 14A 704318
2 logo_surrozenx1.jpg GRAPHIC 80780
3 logo_surrozenx2.jpg GRAPHIC 51458
4 ny20003206x1-pc_1.jpg GRAPHIC 559078
5 ny20003206x1-pc_2.jpg GRAPHIC 490778
  Complete submission text file 0001140361-22-016630.txt   2332555
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 981556622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39635 | Film No.: 22867821
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences